source
- Rapport Therapeutics says it is ready to launch its seizure drug independentlyIn a recent interview, CEO Abe Ceesay explained that Rapport Therapeutics has assembled an investor syndicate and feels fully prepared to bring its seizure drug to market on its own. Founded in 20…
- Veteran researcher warns new OMB grant rule could politicize U.S. scienceDavid J. Skorton, president of the Association of American Medical Colleges, writes that after four decades in research he has never seen a threat to science like the new grantmaking rule being con…